↩ Go Back
Need help?

Businesses for Sale and Investment Opportunities in North Andover

Businesses for Sale and Investment Opportunities in North Andover. Buy or Invest in a Business in North Andover.

Filters
  • North Andover

  • Darshini

 

There were no results matching your filter criteria. Edit filters or checkout recent listings below.
Interested in businesses matching this criteria? Register your requirements below and we'll keep you posted when a matching business registers.

Create Investor Profile

Timeshare Investment Opportunity in North Andover, United States

Business distributes vacation rentals at non-public wholesale rates to millions of private members.
- We are the first and only major distributor of vacation rentals of hotels to the private online travel agent industry. - Vacation Rentals are now mainstream and listed alongside hotels on major OTAs, such as Booking. com, TripAdvisor, and Expedia. - Vacation Rentals have yet to be offered to the 20% of the hotel distribution industry – or $39B per year of hotel bookings – that serves corporate America & other private institutions on POTAs. - With 9 out of 10 Vacation Rental managers approached by us agreeing to list with us at wholesale rates, it is clear this is about to change! - As innovators in vacation rentals for over 15 years, and after 18 months of beta testing, we are proving that offering vacation rentals at wholesale rates through the POTA industry is the most exciting opportunity in travel today.
Business distributes vacation rentals at non-public wholesale rates to millions of private members.
8.1   North Andover
Run Rate Sales
USD 300 thousand
EBITDA Margin
14 %
Financial Investment
USD 175 K for 24%
Contact Business

Profitable Moving Company Seeking Loan in Boston, United States

Highly rated relocation company in Boston serving households and businesses seeking loan for expansion.
- We move homes of all sizes, and businesses in most sectors and also perform specialty moving services. - Our peak season is from May to September. - Licensed & insured. - Highly rated on Google. (4.9/5) and we receive our bookings through our online website. - We have served 8 commercial clients until now and are in talks with new clients. - Currently, the business has been downsized due to working capital requirements. - We have reduced the advertising budget due to which sales are going slow this year. - The manpower, and truck for any booking are contractual and are rented for each booking.
Highly rated relocation company in Boston serving households and businesses seeking loan for expansion.
8.0   Boston
Run Rate Sales
USD 24 thousand
EBITDA Margin
35 %
Business Loan
USD 30 K at 8%
Contact Business

Pet Food Company Seeking Loan in Dedham, United States

Contract manufacturers for the CBD/wellness industry based in the US seek loan for expansion.
- We are a rapidly growing manufacturer serving the CBD/wellness industry in North America. - Company is listed on the CSE and OTC and is looking for a lender to fuel growth. - Our clients include a wide variety of CBD/wellness consumer product companies in the US and Canada. - Have around 80 clients. - We are a public company with 26,000 shareholders and we owe around USD 450,000 to a small group of lenders.
9.5   Dedham
Run Rate Sales
USD 3.6 million
EBITDA Margin
15 %
Business Loan
USD 2.5 Mn at 15%
Contact Business

Profitable Digital Marketing Company Investment Opportunity in Boston, United States

Zero-based marketing agency increasing ROI by decreasing waste and identifying latent opportunity seeks investment.
- We are an early-stage start-up focused on zero-based marketing, we help our clients optimize results (typically starting with digital media and social) and increase ROI by reducing digital marketing waste and identifying latent opportunities using proprietary data and ML/AI. - Our client acquisition strategy is based on social media marketing and mainly through LinkedIn. - We target fortune 500 companies and have proven we can deliver 10%-30% competitive efficiency in digital marketing optimization/savings. - As we are a newly established company, we have only 1 client at the moment. - Our valuation is based on our competitive edge, marketing strategy and orchestration, ML/AI back-end that drives results against business strategy, proven ability to optimize media and marketing up to 10%-30%.
7.4   Boston
Run Rate Sales
USD 480 thousand
EBITDA Margin
40 %
Financial Investment
USD 150 K for 5%
Contact Business

Sportswear Business for Sale in Ludlow, United States

For Sale: Apparel brand focused on custom soccer uniforms with internal designs and outsourced manufacturing.
- We are a sports apparel brand that mainly designs custom uniforms. We also provide other products like backpacks and soccer balls. Typically our clients are soccer clubs and teams. - Have active contracts with around 8 large clubs and a lot of other small teams. - Primarily we market and sell products through our website and Shopify, but also have a DTC marketing strategy with clubs. - We are targeting the US market, but have had overseas clients as well. Shipping is challenging overseas so we focus on the US town clubs and premier club markets because of large volume orders. - Products are designed by us and manufacturing is outsourced. - There is no limit on manufacturing capacity as our manufacturing partner has strong roots in meeting our demands easily. Our manufacturing partner can produce more than 40,000 soccer uniforms per month so there is a lot of room for growth. - With Covid-19, we took a hit but are back to doing steady business. We were able to recover without a lot of efforts, in the hands of the right investor, this business can become a national brand in soccer.
For Sale: Apparel brand focused on custom soccer uniforms with internal designs and outsourced manufacturing.
8.3   Ludlow
Run Rate Sales
USD 120 thousand
EBITDA Margin
45 %
Business for Sale
USD 120 K
Contact Business

Enterprise Software Company for Sale in Boston, United States

B2B CRM software provider with 200-300 clients providing services to over 50 different business verticals.
- We offer SaaS based CRM services to our clientele. - Company was incorporated in the US and have a sister concern in India. The Indian entity is up for sale. - Offer an innovative and highly advanced CRM software to business clients with an excellent UI and plenty of functions. - Have over 200-300 clients registered and charge USD 30 - USD 50 per head. Clients come from a variety of industries. Offer services to over 50 different verticals from bakery businesses to technology providers for NASA. - It is an enterprise grade product that is suitable for any customer who is trying to streamline sales, marketing, and customer service/retention functions. - Monthly recurring revenue is growing rapidly. This creates outstanding life time value that is coupled with a highly profitable business. There is no revenue concentration meaning no threat from a small set of high paying customers leaving and materially impacting companies performance. Revenues are spread very evenly over the entire customer base. - Have a comprehensive and extensive marketing strategy that includes digital and social media marketing and print advertising.
8.2   Boston
Run Rate Sales
USD 700 thousand
EBITDA Margin
30 - 40 %
Business for Sale
USD 9 Mn
Contact Business

Profitable Medical Imaging Systems Company Investment Opportunity in Massachusetts, United States

Company based in the US that designs, engineers and manufactures revolutionary medical devices.
- We are rapidly finalizing worldwide distribution agreements. Those companies have rejected our competitors and have standardized on our product. - Our major sales channel has sixty-five (65) salespeople promoting the product. - Our technology is more cost-effective than those of our competitors. - Our patented IP, and our existing distributor network, have tremendous value, - We have not yet found a patient, no matter how sick, where our device could not find veins.
Company based in the US that designs, engineers and manufactures revolutionary medical devices.
9.7   Massachusetts
Run Rate Sales
USD 180 thousand
EBITDA Margin
50 %
Financial Investment
USD 500 K for 10%
Contact Business

Entertainment Center for Sale in Massachusetts, United States

For Sale: Recreation center with bowling, video games, min-golf, pool, ice cream stalls.
The business that is being offered for sale consists of a recreation center that has been in continuous operation under the direction of the original family member who built it sixty years ago, but it has been operated by hired personnel. It consists of a 20,000 square foot building occupied by a 24-lane bowling center, pool tables and video games. Also, there is an 18-hole mini-golf course and an ice cream stand both of which operate seasonally. Along with these operations is nearly three acres of land. The site can easily accommodate another 20,000 square feet of buildings. While sixty years old, the complex has been carefully and lovingly maintained. The complex is located on an important road that separates two cities by around six miles that has around a 30,000 car per day traffic count. The population of the general business area is somewhat over 100,000. Being 40 miles from Boston, it has gradually become more bedroom than factory. The business that employs seven, some full timers and some part timers both of whom have been with us for years, is breakeven at the moment. The buyer will get the keys to the operation plus the land and building. It is located in the state of Massachusetts, USA. We think the operation would represent a good start for a family looking to immigrate to the USA.
9.5   Massachusetts
Run Rate Sales
USD 2.4 million
EBITDA Margin
Nil
Business for Sale
USD 1.3 Mn
Contact Business

Biotechnology Company Investment Opportunity in Tyngsborough, United States

Bio-technology company involved in nano-particle technology research and development in the bio-medical sector.
- A bio-technology research and development company based in Tyngsborough, Massachusetts. - We do R&D in nano-particle technology for the bio-medical research sector. - We license our technologies to other bio-medical companies, and companies belonging to the agriculture sector. - We collaborate with The National Institute of Health. - We are seeking funds to get one of the new research projects approved by FDA. - Physical assets include machines and equipment. The facility is rented.
Bio-technology company involved in nano-particle technology research and development in the bio-medical sector.
8.1   Tyngsborough
Run Rate Sales
USD 180 thousand
EBITDA Margin
0 - 10 %
Financial Investment
USD 375 K for 50%
Contact Business

Profitable Beauty Product Shop for Sale in Boston, United States

Company sells Vitamin C facial serum and other cosmetics that clears and rejuvenates skin.
- Some of our products include a Vitamin C facial serum, retinol moisturizer, facial marks and teeth whiteners. - Supplier of the products also makes other products in this area and the investor can increase the number of product offerings easily. - Over USD 1,000,000 in revenue over the life of the business with over 25,000 paying customers. - Year-to-Date average order value of USD 42 since inception of the company. - 30% of revenue comes from email marketing and an email marketing agency handles all of the email campaigns. - Have a strong social media presence with 10,600 Instagram followers and 14,000 followers on Facebook. - Day-to-Day mundane tasks have been outsourced to virtual assistants in the Philippines allowing owner to focus on marketing. - Automated fulfilment with a third party fulfilment center handling inventory and shipping. - The firm does not have any physical assets but owns a website and technology to run the website.
Company sells Vitamin C facial serum and other cosmetics that clears and rejuvenates skin.
7.5   Boston
Run Rate Sales
USD 1 million
EBITDA Margin
24 %
Business for Sale
USD 445 K
Contact Business

Sports Footwear Company Investment Opportunity in Boston, United States

Outdoor athletic footwear company looking for investment to launch sales.
- We are an outdoor athletic footwear company that is yet to start our retail operations. - Have completed R&D and have developed footwear that is perfect for adventure travel. - Our product maintains high quality and high performance of hiking boots without the need to pack multiple footwear. - Founder has over 35 years of experience as an entrepreneur in the sporting goods industry. - We plan to achieve sales in North America via eCommerce portals and wholesale partners with up to 200 retail doors.
Outdoor athletic footwear company looking for investment to launch sales.
6.9   Boston
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 250 K for 10%
Contact Business

Optical Store for Sale in Boston, United States

Optical business based in Boston having 2 stores, and receiving 8-10 customers on a daily basis.
- Optical business located in Boston with two outlets operating since 2012. - Have 5 vendors from whom we purchase the products. - On an average, we receive 8-10 customers at each outlet on a daily basis. - We also receive around 2-3 online orders per day through third party websites. - We provide prescription eye wear, contact lenses, sunglasses. - Have 5 star rating on Facebook and Yelp. - Promoter has more than 8 years of experience in this business.
Optical business based in Boston having 2 stores, and receiving 8-10 customers on a daily basis.
6.6   Boston
Run Rate Sales
USD 420 thousand
EBITDA Margin
14 %
Business for Sale
USD 500 K
Contact Business

Building Maintenance Franchise Opportunity

Midtown Chimney Sweeps Franchising, Established in 1979, 30 Franchisees, Littleton Headquartered
  • 1000+ Page Views
  • 200+ Investor Views
Midtown Chimney Sweeps Franchising was incorporated in the year 1979. The founder is an second generation fireplace and chimney technician who wanted to create the system he always wished he had. He knew the components that a business in the hearth industry needed to be successful, and he was determined to put them together. He visited companies throughout the industry to discover what was working, and what wasn’t. As a result, Byron developed a world-class marketing and Customer Relationship Management system that gains customer’s loyalty and rewards the business owner. This system is the first full scale, systems-driven, marketing oriented chimney franchise in the U. S. and it’s now available to you. With Midtown Chimney Sweeps, your business can hit the ground running.
Midtown Chimney Sweeps Franchising, Established in 1979, 30 Franchisees, Littleton Headquartered
8.8   Expanding in Boston
Exp Monthly Sales
USD 9 thousand
Space Required
100 - 400 Sq Ft
Investment Required
USD 39 - 105 K
Contact Company

Bio Therapeutic Drugs Business Investment Opportunity in Manlius, United States

Company developing diagnostics & therapeutics for skin cancer: basal cell carcinoma, squamous cell carcinoma, melanoma.
- The company currently works with pharmaceutical and diagnostic companies, research institutes, CROs, and CDMOs to help them develop molecular bioassays and digital pathology products, and to visualize and analyze the resultant data via AI and ML for the benefit of patients, their family, and their healthcare providers. - Currently, has 3 clients: Klotho Therapeutics Inc. (a biotechnology company in San Diego, CA, USA), Unger Medical PC (a hair restoration medical practice in NY, NY, USA), and Astrix Technology Group (a life sciences strategy, technology, and staffing services company based in Red Bank, NJ, USA). • Target Market: - The business is specialized in developing diagnostics and therapeutics for human basal cell carcinoma, squamous cell carcinoma, and melanoma. This skin cancer group comprises the most diagnosed cancers worldwide of all cancer types with over five million cases diagnosed each year. - The skin cancer therapeutics diagnostics and therapeutics products industry worldwide were worth $8.2 billion USD in 2019 and is projected to reach $15 billion by 2027. This represents a CAGR of 7.5%. - What share of the total skin cancer target market can we estimate is realistic for to obtain? A conservative estimate is that our company should be able to reach $150 million USD in annual revenues by the close of 2028. • Problem or Need: - The main project involves the development of a Skin Cancer Patient Data Blockchain. - Currently there is a serious problem concerning how oncology patients organize and share their medical data, how companies get access to this data, and a lack of return in value to the patients for sharing their personal data. The blockchain is designed to tackle and solve these problems. - The blockchain for skin cancer patients will be comprised of multiple decentralized nodes contributing data to a shared ledger where patients can set up smart contracts to share and control their data. - Skin cancer patients will be able to share their data with research institutions, drug companies, diagnostic companies, contract research organizations, client trials organizers, and other stakeholders. - Also, planning to launch a medium of exchange within the blockchain system to allow patients to be given money for participation in the sharing of their data with the mentioned company stakeholders. - Therefore, the company stakeholders that plan to utilize the patient’s data would provide revenues and income to support the operations of the blockchain. - For example, pharmaceutical companies would be important customers that the business would cultivate as users of the patient’s healthcare data. This is because pharma companies can use this blockchain to discover patients with the right profile for a skin cancer clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. This should greatly streamline for the pharma company the time it takes to enroll the right patients into clinical trials and get them started. • Solution: - What is the core value proposition? For the company stakeholders in the skin cancer patient blockchain, the business is hoping to demonstrate that this blockchain technology will be a way to improve business outcomes through better efficiency, risk management, and security. - For these customers, this will enable them to maintain and capture new sources of profit. At the same time, company stakeholder participation will also grow the business as the integrator and host of the blockchain and result in significant profit growth for the company. • Team: The team is comprised of: - Founder, President, and CEO, a 100% full-time permanent employee has a Ph. D. in Cell and Molecular Biology from St. John’s University (New York, NY), a M. S. in Microbiology & Immunology from Long Island University, and a M. B. A. from Le Moyne College. In addition, he has 20 years of quality assurance and regulatory affairs experience at the Bristol-Myers Squibb Company, Charles Rivers Laboratories, and Vybion, Inc. This includes moving numerous human therapeutic products from R&D, through clinical trials, and into the marketplace via approval by the US FDA and worldwide regulatory bodies. In addition to the above experience, and an addition 18 year of experience in human therapeutics research and development and in the management of laboratory-based cell culture, toxicological, or bioassay projects within the biopharmaceuticals industry. However, he is a Senior Member of the food, drugs & cosmetics section of the American Society for Quality (ASQ), and a society member of The American Association for the Advancement of Science (AAAS). - The President of Hillberg Consulting is a part-time, non-permanent hourly contract employee of R&D department. She is an accomplished executive and board member with a reputation for delivering bottom-line profitability while building the infrastructure to support growth and success. She has served at Johnson & Johnson Ortho Clinical Diagnostics as VP of R&D, and as Chief Technology, Officer at Carestream Health. Holly has a B. S. in Chemical Engineering from Michigan Technology University and a M. S. in Electrical Engineering from Rochester Institute of Technology. - Marketing Consultant - part-time, non-permanent hourly employee. He is a professional engineer and entrepreneurial executive with focus on emerging technology solutions applied to real world problems. He has substantial experience in team building and in developing market strategies & partnerships. This includes over two decades of technology & networks business planning, development, & implementation. He has a Masters in Entrepreneurial Studies - MIT Sloan School of Management, and M. S. & B. S. in Engineering from Syracuse U. and Utica College. - Blockchain Development Technical Project Management Consultant - Part-time, non-permanent hourly employee that is a contractor from EffectiveSoft Corporation, San Diego, CA. She has eight years of experience as VP of Service Delivery and as the Head of Sales for enterprise level software solutions at Effective Soft Corp. She has a M. B. A. from The University of Manchester and a B. S. degree from Minsk State Linguistics U. – Legal Counsel - Part-time, non-permanent hourly contract employee. He holds the Juris Doctor from Boston College Law School, and B. A. in Political Science from Binghamton University. He is a Partner at Newman & Lickstein, with eight years of experience in representing technology companies and investors in licensing, IP development, real estate, mergers & acquisitions, and business litigation. - Demonstrating results to stakeholders will be the key to success. For skin cancer, there is a lot of data collected from various heterogeneous sources – pathology imaging data, genetic testing, surgery, drugs intervention, payer, and insurance information, etc. - Some companies are using a website or app to meet the social needs of patients to discuss their concerns with other patients or a few qualified physicians. No competitor is comprehensively focusing on skin cancer data & treatment to the level that we do. Possible competitors have thus not yet integrated the patient data, shared consent, and the patient monetization blocks together into a comprehensive and workable blockchain system for skin cancer patients, or for any segment of the oncology market, for that matter. - This team, on the other hand, has decades of experience in oncology research, the development of products and services for cancer patients, in oncology clinical biomedicine and in oncology marketing, and that makes the company well-equipped to solve the problems around skin cancer patient data acquisition, its organization, and its beneficial use for the patients and for their healthcare providers. For example, regarding the latter, the company also harnesses artificial intelligence (AI) and machine learning (ML) to extract relevant data from the patient’s database that will help healthcare providers to better understand the patient’s tumor and the tumor microenvironment (i. e. , tumor growth, cellular migration, blood supply to the tumor, subcellular trafficking, and tumor metastasis), drug efficacy (including drug penetration into the tumor, possible tumor shrinkage or tumor death, and drug toxicity, and side effects), or the immediate or long term results of surgical intervention. - When competitors enter this specific market, the business plans to stand out by utilizing a value-based strategy that clearly displays our brand and the above competitive advantage. • Traction: - Currently works with pharmaceutical and diagnostic companies, research institutes, and contract research development and manufacturing companies to help them obtain and organize their molecular bioassays and pathology data. We propose to utilize this traction and intercompany personal connections to gain and grow customers that will use and pay for patient data on the blockchain. - Also use social media & patient advocacy organization to recommend the blockchain to skin cancer patients so that we can grow the patient database. - The company is also a member of the Hyperledger Foundation Healthcare Special Interest Group. Hyperledger, as part of the Linux Foundation, provides technology leaders a uniquely open and collaborative international community from which to develop, validate, and field enterprise-grade blockchain technology solutions. It is the mandate of the Hyperledger Healthcare Special Interest Group (HC-SIG) to represent healthcare professionals and technologists, to globally unite these individuals, and to advance the state of the healthcare industry through the implementation of technology solutions using blockchain technologies in general, and the umbrella of Hyperledger frameworks and toolsets specifically. • Revenue Model: - Within the ecosystem surrounding the above patients, who would buy/lease the skin cancer blockchain services that the company wish to market? In this blockchain system, individuals will be allowed to store and monetize their own health data including blood test results, medical history, genetic profile, skin photographs, pathology images and other sensitive information. - In the healthcare marketplace, cancer patients would be paid in stablecoin currency to lease their individual data to companies for a certain amount of time. - Pharmaceutical (pharma) companies would be important customers that the company would cultivate as users of the patient’s permitted healthcare data. - Blockchain can help pharma companies discover patients with the right profile for a clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. - According to Milind Kamkolkar, chief data officer at Sanofi, patients could be prompted based on their data to join a clinical trial, thereby also accelerating the process and accuracy of trial recruitment. Using this blockchain if a person declines, no personal information will be shared, and the person's identity will remain private. If the person agrees, the overall process will move faster by abolishing the need for intermediaries. - For pharma companies, better inclusion in clinical trials and better reproducibility for studies can reduce the time and money needed to develop new drugs. - Besides pharma companies, research institutes will be willing to pay for the data from skin cancer patients, and the introduction of our blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely after the latter have obtained consent from individual patients. - How are the products and services going to generate revenue? The most straightforward way to generate revenue is to have the blockchain client customers pay for the products and services that exceeds by a large margin what it costs to develop and operate the blockchain (a cost-plus strategy). - When competitors enter this specific market, plan to stand out by utilizing a value-based strategy that clearly displays the brand and competitive advantage. • Market Projections: - What share of the total skin cancer blockchain target market can we estimate is realistic for to obtain? The global skin cancer blockchain customer market size stood at USD 8.19 billion in 2019 and is projected to reach USD 14.55 billion by 2027, exhibiting a CAGR of 7.5% during the forecast period. A conservative estimate is that the company should be able to reach $150 million in annual revenues in 4 years. - These financial projections would be possible because of the company participating and partnering with individuals and companies within the oncology community to create superior value for the products and services. - Over the next 4 years, the company anticipates receiving funding from investors, and revenues from pharmaceutical companies and research institute customers. - However, expenditures are also expected to increase. Expenses incurred will be for the development of products and services, and for personnel, equipment, supplies, business development & marketing. • Competition: - Have identified Nebula Genomics and Longenesis as competition. These two leading firms in artificial intelligence and blockchain technology for healthcare, are developing a platform for the storage and exchange of genomic data. - Nebula Genomics is a San Francisco-based biotechnical company that uses blockchain to “build a marketplace” for clinical genetics data. - Longenesis is a Hong Kong-based partnership between Insilico Medicine and the Bitfury Group, which makes blockchain platforms for the exchange of health data. - The above companies will reportedly apply artificial intelligence and blockchain technology to develop a platform for individuals and large data providers to store, manage, exchange, and profit from genomic and other types of clinical data. To automate data acquisition, the project developed by both Nebula Genomics and Longenesis will utilize smart contracts. - Unlike the Nebula Genomics and Longenesis blockchains, this blockchain project will be focused on oncology patients and the ecosystem around them rather than on a multitude of disease sectors. - In addition to Nebula Genomics and Longenesis, the U. S. -based life science research marketplace, Scientist. com, has revealed the development of a pharmaceuticals blockchain platform. This latter blockchain-powered platform is reportedly designed to track and protect pharmaceutical data. Thus, the Scientist. com DataSmart TM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered before submission to regulators such as the FDA and the EMEA. - However, the above platforms do not adequately address the pressing concerns of cancer patients regarding the control and sharing of their personal data. Competitive Advantage: • Strategy. Specifically for oncology blockchain products, the major company players that may join our blockchain to gain access to data from skin cancer patients include: Almirall S. A. Amgen, Inc. Boehringer Ingelheim GmbH. Bristol-Myers Squibb Company. Eli Lilly and Company. Elekta AB. F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc. Merck & Co. , Inc. Mylan NV. Novartis AG. Pfizer. Regeneron. Sanofi. Sun Pharmaceutical Industries Ltd. Varian Medical Systems, Inc. Sensus Healthcare. ICAD, Inc. Accuray, Inc.
Company developing diagnostics & therapeutics for skin cancer: basal cell carcinoma, squamous cell carcinoma, melanoma.
9.5   Manlius
Run Rate Sales
USD 26 thousand
EBITDA Margin
35 %
Financial Investment
USD 1 Mn for 25%
Contact Business

Profitable Cosmetics Company for Sale in Austin, United States

Olive oil vegan skin care. Need ceo/markinging dollars. Plug and play all heavy lifting done.
22,000 active email. The product truly works. Former Elle beauty editor thinks it’s the best vegan line in the market better then true botanical at much more approachable pricing.
8.3   Austin
Run Rate Sales
USD 60 thousand
EBITDA Margin
50 %
Business for Sale
USD 525 K
Contact Business

Frequently
Asked
Questions

  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more